Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

Roger Stupp; Monika E Hegi; Thierry Gorlia; Sara C Erridge; James Perry; Yong-kil Hong; Kenneth D Aldape; Benoit Lhermitte; Torsten Pietsch; Danica Grujicic; Joachim Peter Steinbach; Wolfgang Wick; Rafał Tarnawski; Do-hyun Nam; Peter Hau; Astrid Weyerbrock; Martin J B Taphoorn; Chiung-chyi Shen; Nalini Rao; László Thurzo; Ulrich Herrlinger; Tejpal Gupta; Rolf-dieter Kortmann; Krystyna Adamska; Catherine Mcbain; Alba A Brandes; Joerg Christian Tonn; Oliver Schnell; Thomas Wiegel; Chae-yong Kim; Louis Burt Nabors; David A Reardon; Martin J Van den bent; Christine Hicking; Andriy Markivskyy; Martin Picard; Michael Weller

doi:10.1016/S1470-2045(14)70379-1

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

Roger Stupp, Monika E Hegi, Thierry Gorlia, Sara C Erridge, James Perry, Yong-kil Hong, Kenneth D Aldape, Benoit Lhermitte, Torsten Pietsch, Danica Grujicic, Joachim Peter Steinbach, Wolfgang Wick, Rafał Tarnawski, Do-hyun Nam, Peter Hau, Astrid Weyerbrock, Martin J B Taphoorn, Chiung-chyi Shen, Nalini Rao, László ThurzoUlrich Herrlinger, Tejpal Gupta, Rolf-dieter Kortmann, Krystyna Adamska, Catherine Mcbain, Alba A Brandes, Joerg Christian Tonn, Oliver Schnell, Thomas Wiegel, Chae-yong Kim, Louis Burt Nabors, David A Reardon, Martin J Van den bent, Christine Hicking, Andriy Markivskyy, Martin Picard, Michael Weller

Deanery of Molecular, Genetic and Population Health Sciences

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1100-1108
Journal	The Lancet Oncology
Volume	15
Issue number	10
DOIs	https://doi.org/10.1016/S1470-2045(14)70379-1
Publication status	Published - 1 Sept 2014

Access to Document

10.1016/S1470-2045(14)70379-1

https://linkinghub.elsevier.com/retrieve/pii/S1470204514703791

Cite this

Stupp, R., Hegi, M. E., Gorlia, T., Erridge, S. C., Perry, J., Hong, Y., Aldape, K. D., Lhermitte, B., Pietsch, T., Grujicic, D., Steinbach, J. P., Wick, W., Tarnawski, R., Nam, D., Hau, P., Weyerbrock, A., Taphoorn, M. J. B., Shen, C., Rao, N., ... Weller, M. (2014). Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial. The Lancet Oncology, 15(10), 1100-1108. https://doi.org/10.1016/S1470-2045(14)70379-1

@article{e29b6709eb09478bafc71a9636de42ec,

title = "Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial",

author = "Roger Stupp and Hegi, {Monika E} and Thierry Gorlia and Erridge, {Sara C} and James Perry and Yong-kil Hong and Aldape, {Kenneth D} and Benoit Lhermitte and Torsten Pietsch and Danica Grujicic and Steinbach, {Joachim Peter} and Wolfgang Wick and Rafa{\l} Tarnawski and Do-hyun Nam and Peter Hau and Astrid Weyerbrock and Taphoorn, {Martin J B} and Chiung-chyi Shen and Nalini Rao and L{\'a}szl{\'o} Thurzo and Ulrich Herrlinger and Tejpal Gupta and Rolf-dieter Kortmann and Krystyna Adamska and Catherine Mcbain and Brandes, {Alba A} and Tonn, {Joerg Christian} and Oliver Schnell and Thomas Wiegel and Chae-yong Kim and Nabors, {Louis Burt} and Reardon, {David A} and {Van den bent}, {Martin J} and Christine Hicking and Andriy Markivskyy and Martin Picard and Michael Weller",

year = "2014",

month = sep,

day = "1",

doi = "10.1016/S1470-2045(14)70379-1",

language = "English",

volume = "15",

pages = "1100--1108",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "10",

}

Stupp, R, Hegi, ME, Gorlia, T, Erridge, SC, Perry, J, Hong, Y, Aldape, KD, Lhermitte, B, Pietsch, T, Grujicic, D, Steinbach, JP, Wick, W, Tarnawski, R, Nam, D, Hau, P, Weyerbrock, A, Taphoorn, MJB, Shen, C, Rao, N, Thurzo, L, Herrlinger, U, Gupta, T, Kortmann, R, Adamska, K, Mcbain, C, Brandes, AA, Tonn, JC, Schnell, O, Wiegel, T, Kim, C, Nabors, LB, Reardon, DA, Van den bent, MJ, Hicking, C, Markivskyy, A, Picard, M & Weller, M 2014, 'Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial', The Lancet Oncology, vol. 15, no. 10, pp. 1100-1108. https://doi.org/10.1016/S1470-2045(14)70379-1

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial. / Stupp, Roger; Hegi, Monika E; Gorlia, Thierry et al.
In: The Lancet Oncology, Vol. 15, No. 10, 01.09.2014, p. 1100-1108.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

AU - Stupp, Roger

AU - Hegi, Monika E

AU - Gorlia, Thierry

AU - Erridge, Sara C

AU - Perry, James

AU - Hong, Yong-kil

AU - Aldape, Kenneth D

AU - Lhermitte, Benoit

AU - Pietsch, Torsten

AU - Grujicic, Danica

AU - Steinbach, Joachim Peter

AU - Wick, Wolfgang

AU - Tarnawski, Rafał

AU - Nam, Do-hyun

AU - Hau, Peter

AU - Weyerbrock, Astrid

AU - Taphoorn, Martin J B

AU - Shen, Chiung-chyi

AU - Rao, Nalini

AU - Thurzo, László

AU - Herrlinger, Ulrich

AU - Gupta, Tejpal

AU - Kortmann, Rolf-dieter

AU - Adamska, Krystyna

AU - Mcbain, Catherine

AU - Brandes, Alba A

AU - Tonn, Joerg Christian

AU - Schnell, Oliver

AU - Wiegel, Thomas

AU - Kim, Chae-yong

AU - Nabors, Louis Burt

AU - Reardon, David A

AU - Van den bent, Martin J

AU - Hicking, Christine

AU - Markivskyy, Andriy

AU - Picard, Martin

AU - Weller, Michael

PY - 2014/9/1

Y1 - 2014/9/1

U2 - 10.1016/S1470-2045(14)70379-1

DO - 10.1016/S1470-2045(14)70379-1

M3 - Article

SN - 1470-2045

VL - 15

SP - 1100

EP - 1108

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 10

ER -